Insiders · ENZ

David Bench

Officer at Enzo Biochem Inc (ENZ)

David Bench has filed 4 insider reports with the SEC since February 2022, as officer at Enzo Biochem Inc (ENZ). David Bench made no open-market purchases or sales in the last 12 months. In the latest filing, on June 15, 2022, David Bench bought 3,500 shares of Enzo Biochem Inc (ENZ) for $7,525 at an average of $2.15.

Filings
4
Companies
1
Bought on market
$7,525
Sold on market
None

Companies where David Bench is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Enzo Biochem Inc logo
ENZ
Enzo Biochem Inc
Officer$7,525$2.15Jun 15, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare David Bench with

Other insiders at the same companies

Questions about David Bench

What is David Bench's role at Enzo Biochem Inc?
David Bench reports to the SEC as officer at Enzo Biochem Inc (ENZ), according to the latest filing on June 15, 2022.
Has David Bench bought or sold stock recently?
The most recent open-market purchase was on June 14, 2022: bought 3,500 shares of Enzo Biochem Inc (ENZ) for $7,525 at an average of $2.15.
How do I get alerts when David Bench files?
Follow David Bench on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Bench (SEC CIK 0001797876). Totals count each trade once, skipping amendments whose original is on file, from Feb 16, 2022 on. View on SEC EDGAR · Get this as JSON